Clinical Trials Logo

Ampulla of Vater Cancer clinical trials

View clinical trials related to Ampulla of Vater Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05690412 Recruiting - Ampullary Cancer Clinical Trials

Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.

PaNETh
Start date: April 1, 2022
Phase:
Study type: Observational

The aim of our study is to provide data on the efficacy and safety of endoscopic papillectomy, by including consecutive patients treated after 2015, when first guidelines on endoscopic management of ampullary neoplasms were available.

NCT ID: NCT03139487 Recruiting - Pancreatic Cancer Clinical Trials

A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

PRIORITY
Start date: August 7, 2017
Phase: Phase 2
Study type: Interventional

This is an open label, multi-center, and randomized phase II trial designed to compare the safety and efficacy of direct oral anticoagulants and subcutaneous dalteparin in patients with acute venous thromboembolism and upper gastrointestinal, hepatobiliary, or pancreatic cancer, based on a group sequential design. Enrolled patients will be randomized in a 1:1 ratio. Patients will be stratified by performance status, type of cancer, chemotherapy and medical centers.

NCT ID: NCT00809081 Recruiting - Pancreas Cancer Clinical Trials

Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy

Start date: July 2007
Phase: Phase 3
Study type: Interventional

Pancreaticoduodenectomy is associated with a high incidence of postoperative complications. These postoperative complications could delay postoperative resumption of adequate oral intake. Clinical study on postoperative feeding after pancreaticoduodenectomy is very limited. Method of Nutritional support (Enteral feeding or total parenteral support)after pancreaticoduodenectomy is controversial. 1. To evaluate whether early enteral nutrition may be a suitable alternative to total parenteral nutrition 2. To evaluate whether enteral feeding improve nutritional status after pancreaticoduodenectomy